GH

Gunnar J. Hanson

GS G.D. Searle: 105 patents #5 of 659Top 1%
ST Sarepta Therapeutics: 39 patents #1 of 64Top 2%
JP Joyant Pharmaceuticals: 13 patents #1 of 12Top 9%
PH Pharmacia: 11 patents #36 of 528Top 7%
SE Serenex: 5 patents #2 of 22Top 10%
MIT: 3 patents #1,739 of 9,367Top 20%
University Of Texas System: 3 patents #1,041 of 6,559Top 20%
C& C.D. Searle &: 2 patents #1 of 16Top 7%
PI Pharmacia Corporation (Of Pfizer, Inc.): 1 patents #1 of 42Top 3%
MU Murdoch University: 1 patents #7 of 19Top 40%
UN Unknown: 1 patents #29,356 of 83,584Top 40%
📍 Cambridge, MA: #8 of 8,183 inventorsTop 1%
🗺 Massachusetts: #57 of 88,656 inventorsTop 1%
Overall (All Time): #4,169 of 4,157,543Top 1%
181
Patents All Time

Issued Patents All Time

Showing 1–25 of 181 patents

Patent #TitleCo-InventorsDate
12377150 Exon skipping oligomer conjugates for muscular dystrophy Marco A. Passini 2025-08-05
12370261 Chimeric peptides for antisense delivery Bradley L. Pentelute, Colin M. Fadzen, Rebecca L. Holden, Justin Wolfe, Zi-Ning Choo +1 more 2025-07-29
12239715 Peptide oligonucleotide conjugates Ming Zhou 2025-03-04
12168059 Trimeric peptides for antisense delivery Justin Wolfe, Colin M. Fadzen, Bradley L. Pentelute 2024-12-17
12138312 Cell-penetrating peptides for antisense delivery Justin Wolfe, Colin M. Fadzen, Zi-Ning Choo, Rebecca L. Holden, Monica Yao +1 more 2024-11-12
12121532 Modified antisense oligomers for exon inclusion in spinal muscular atrophy Marco A. Passini 2024-10-22
11732259 Peptide oligonucleotide conjugates 2023-08-22
11672871 Peptide oligonucleotide conjugates Ming Zhou 2023-06-13
11674139 Oligonucleotides for treating expanded repeat diseases Peter S. Linsley, Brian James Leppert 2023-06-13
11642364 Exon skipping oligomer conjugates for muscular dystrophy Marco A. Passini 2023-05-09
11395855 Exon skipping oligomer conjugates for muscular dystrophy Marco A. Passini 2022-07-26
11382981 Exon skipping oligomer conjugates for muscular dystrophy Marco A. Passini 2022-07-12
11338041 Exon skipping oligomer conjugates for muscular dystrophy Marco A. Passini, Frederick Joseph SCHNELL 2022-05-24
11236338 Antisense-induced exon2 inclusion in acid alpha-glucosidase Stephen Donald Wilton, Sue Fletcher, Richard K. Bestwick 2022-02-01
11225662 Peptide oligonucleotide conjugates 2022-01-18
11208655 Functionally-modified oligonucleotides and subunits thereof Dwight D. Weller, Bao Zhong Cai, Ming Zhou 2021-12-28
11097011 Peptide oligonucleotide conjugates Ming Zhou 2021-08-24
11020417 Methods and compounds for treatment of lymphocyte-related diseases and conditions Dan V. Mourich, Frederick Joseph SCHNELL, Johannes Christian Dworzak 2021-06-01
11000600 Exon skipping oligomer conjugates for muscular dystrophy Marco A. Passini 2021-05-11
10927378 Compound and method for treating myotonic dystrophy Ryszard Kole 2021-02-23
10905709 Modified antisense oligomers for exon inclusion in spinal muscular atrophy Marco A. Passini 2021-02-02
10888578 Exon skipping oligomer conjugates for muscular dystrophy Marco A. Passini 2021-01-12
10765760 Exon skipping oligomer conjugates for muscular dystrophy Marco A. Passini, Frederick Joseph SCHNELL 2020-09-08
10760078 Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups Alexander Charles Rudolph, Bao Zhong Cai, Ming Zhou, Dwight D. Weller 2020-09-01
10675356 Peptide oligonucleotide conjugates Ming Zhou 2020-06-09